All articles by Staff Writer
Staff Writer
Innovative diagnostics and the use of AI allow individualised approaches in performance medicine, prevention of injuries and therapy
High calibre speakers at the MEDICA MEDICINE + SPORTS CONFERENCE illuminate new methods and their practical uses
QIAGEN launches API to streamline access to world-leading biomedical data for AI integration
Venlo, the Netherlands, and Redwood City, California, September 11, 2023 – QIAGEN Digital Insights, the bioinformatics business of QIAGEN, today announced the launch of an application programming interface (API) to streamline access for customers from pharma, biotech and academia to its QIAGEN Biomedical Knowledge Base, and enable easy integration of the data into their internal systems.
US FDA Grants Emergency Use Authorisation For ViraDx™
Lumos Diagnostics (ASX: LDX), (“Lumos” or the “Company”) a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that the US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) and a CLIA Waiver (Clinical Laboratory Improvement Amendments) for the ViraDx test which is a combined COVID-19/Flu A/Flu B rapid POC test.
Bruker’s New NeuraLeap Delivers Unprecedented Imaging Speed Across Optical Planes
Novel Use of Digital Micromirror Device Enables Variable Depth-of-Field Collection for Advanced Neuroscience Research
MEDICA LABMED FORUM: four exciting topic days around hot issues, current trends and innovations in laboratory medicine
Important ideas for the entire health market
Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes. Including additional human and mouse targets and introducing dog, cow, and pig targets, the new range provides greater choice and flexibility in conventional and full-spectrum multicolor flow cytometry panels, expanding research capabilities across veterinary immunology research.
QIAGEN Global Oncohematology Summit 2023 – Improving patients’ lives through testing and research
QIAGEN will host the Global Oncohematology Summit 2023, held on September 13 and 14, under the theme “I Can: Improving Patients’ Lives Through Oncohematology Testing and Research”. The virtual event unites experts and patients from around the globe to discuss the latest advances and challenges in oncohematology testing, blood cancer clinical care, and research, focusing on improving patient outcomes. Emphasizing the utmost importance of patients’ perspectives, the summit will feature their testimonies, bringing their voices and considerations to the forefront of the discussion.
Lupin Launches Propranolol Long-Acting Capsules to Improve Heart Health in Canada.
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA (long-acting) capsules,60 mg, 80 mg, 120 mg and 160 mg, in Canada. Propranolol LA is a generic equivalent of Inderal® LA, it provides an effective treatment solution since the discontinuation of Inderal® LA for patients and healthcare practitioners. Propranolol LA’s launch caters to the needs of Canadian patients,reaffirming Lupin’s commitment to enhancing healthcare access and affordability.
Navigating the Future of Neurosurgery: Brain Navi demonstrates NaoTrac and KrystoLens at CNS 2023 & EANS 2023
Brain Navi announced today the demonstration of NaoTrac, a neurosurgical navigation robot and KrystoLens, a single-use neuro-endoscope at CNS 2023 in Washington D.C. and EANS 2023 in Barcelona, respectively.
Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency
Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia. These enhancements incorporate innovative technologies that empower anaesthesiologists to deliver precise anaesthesia, leading to greater patient safety and efficiency throughout the perioperative period.